Provided by Tiger Fintech (Singapore) Pte. Ltd.

ClearPoint Neuro, Inc.

11.80
-0.2200-1.83%
Post-market: 11.820.0200+0.17%19:50 EDT
Volume:4.11M
Turnover:48.36M
Market Cap:333.53M
PE:-15.66
High:12.03
Open:12.03
Low:11.40
Close:12.02
Loading ...

While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership

Simply Wall St.
·
20 Feb

After Leaping 25% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar

Simply Wall St.
·
15 Feb

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

ACCESS Newswire
·
14 Feb

Lake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT)

TIPRANKS
·
13 Feb

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

ACCESS Newswire
·
13 Feb

Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
03 Feb

ClearPoint Neuro (CLPT) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
29 Jan

ClearPoint Neuro Is Maintained at Buy by B. Riley Securities

Dow Jones
·
29 Jan

ClearPoint Neuro (CLPT) Gets a Buy from Lake Street

TIPRANKS
·
28 Jan

B. Riley Raises Price Target on ClearPoint Neuro to $20 From $15, Keeps Buy Rating

MT Newswires Live
·
28 Jan

CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0

Zacks
·
28 Jan

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

ACCESS Newswire
·
28 Jan

ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains?

Zacks
·
22 Jan

ClearPoint Neuro Is Maintained at Buy by Lake Street

Dow Jones
·
22 Jan

ClearPoint Neuro price target raised to $30 from $17 at Lake Street

TIPRANKS
·
21 Jan

Clearpoint Neuro Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
03 Jan